New genes emerging for colorectal cancer predisposition
- PMID: 24587672
- PMCID: PMC3934466
- DOI: 10.3748/wjg.v20.i8.1961
New genes emerging for colorectal cancer predisposition
Abstract
Colorectal cancer (CRC) is one of the most frequent neoplasms and an important cause of mortality in the developed world. This cancer is caused by both genetic and environmental factors although 35% of the variation in CRC susceptibility involves inherited genetic differences. Mendelian syndromes account for about 5% of the total burden of CRC, with Lynch syndrome and familial adenomatous polyposis the most common forms. Excluding hereditary forms, there is an important fraction of CRC cases that present familial aggregation for the disease with an unknown germline genetic cause. CRC can be also considered as a complex disease taking into account the common disease-commom variant hypothesis with a polygenic model of inheritance where the genetic components of common complex diseases correspond mostly to variants of low/moderate effect. So far, 30 common, low-penetrance susceptibility variants have been identified for CRC. Recently, new sequencing technologies including exome- and whole-genome sequencing have permitted to add a new approach to facilitate the identification of new genes responsible for human disease predisposition. By using whole-genome sequencing, germline mutations in the POLE and POLD1 genes have been found to be responsible for a new form of CRC genetic predisposition called polymerase proofreading-associated polyposis.
Keywords: Colorectal neoplasm, genetic predisposition to disease; Genetic variant; Genotype-phenotype correlation; Next generation sequencing; Single nucleotide polymorphism.
Figures
Similar articles
-
Update on genetic predisposition to colorectal cancer and polyposis.Mol Aspects Med. 2019 Oct;69:10-26. doi: 10.1016/j.mam.2019.03.001. Epub 2019 Mar 18. Mol Aspects Med. 2019. PMID: 30862463 Review.
-
Genetic diagnosis of high-penetrance susceptibility for colorectal cancer (CRC) is achievable for a high proportion of familial CRC by exome sequencing.J Clin Oncol. 2015 Feb 10;33(5):426-32. doi: 10.1200/JCO.2014.56.5689. Epub 2015 Jan 5. J Clin Oncol. 2015. PMID: 25559809
-
POLE and POLD1 mutations in 529 kindred with familial colorectal cancer and/or polyposis: review of reported cases and recommendations for genetic testing and surveillance.Genet Med. 2016 Apr;18(4):325-32. doi: 10.1038/gim.2015.75. Epub 2015 Jul 2. Genet Med. 2016. PMID: 26133394 Free PMC article. Review.
-
Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients.Scand J Gastroenterol. 2013 Jun;48(6):672-8. doi: 10.3109/00365521.2013.783102. Epub 2013 Apr 2. Scand J Gastroenterol. 2013. PMID: 23544471
-
Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.Hum Mutat. 2018 Sep;39(9):1214-1225. doi: 10.1002/humu.23564. Epub 2018 Jul 4. Hum Mutat. 2018. PMID: 29900613
Cited by
-
Genetic Testing for Polyposis Syndromes.Clin Colon Rectal Surg. 2016 Dec;29(4):345-352. doi: 10.1055/s-0036-1584087. Clin Colon Rectal Surg. 2016. PMID: 31777466 Free PMC article. Review.
-
Epistatic effect of TLR3 and cGAS-STING-IKKε-TBK1-IFN signaling variants on colorectal cancer risk.Cancer Med. 2020 Feb;9(4):1473-1484. doi: 10.1002/cam4.2804. Epub 2019 Dec 23. Cancer Med. 2020. PMID: 31869529 Free PMC article.
-
Single nucleotide polymorphisms within interferon signaling pathway genes are associated with colorectal cancer susceptibility and survival.PLoS One. 2014 Oct 28;9(10):e111061. doi: 10.1371/journal.pone.0111061. eCollection 2014. PLoS One. 2014. PMID: 25350395 Free PMC article.
-
Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence.Biomedicines. 2020 Nov 10;8(11):489. doi: 10.3390/biomedicines8110489. Biomedicines. 2020. PMID: 33182693 Free PMC article. Review.
-
NUDT7 Loss Promotes KrasG12D CRC Development.Cancers (Basel). 2020 Mar 2;12(3):576. doi: 10.3390/cancers12030576. Cancers (Basel). 2020. PMID: 32131398 Free PMC article.
References
-
- Cohen AM, Shank B, Friedman MA. Colorectal cancer. In: De Vita V, Hellman S, Rosenberg S (eds): Cancer: Principles and Practice of Oncology., editors. Philadelphia: Lippincott; 1989. p. 895.
-
- Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–2917. - PubMed
-
- Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90. - PubMed
-
- Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. CA Cancer J Clin. 1996;46:5–27. - PubMed
-
- Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AM, Bos JL. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525–532. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical